Gestational trophoblastic neoplasia and evidence-based medicine

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 47, Issue 6, 2002, Pages 427-432

  Kohorn, Ernest I ^a  

^a FMB 322 ^*  (United States)

Author keywords

Evidence based medicine; Trophoblastic cancer; Trophoblastic tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; HYDROXYUREA; MELPHALAN; METHOTREXATE; VINCRISTINE; VINCRISTINE SULFATE;

CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK MANAGEMENT; TREATMENT PLANNING; TROPHOBLASTIC DISEASE;

EID: 0036089626     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. The management of high-risk gestational trophoblastic tumours (GTT)
2. Presentation and management of persistent gestational trophoblastic disease and gestational trophoblastic tumors in the USA
3. Late toxicity after therapy of gestational trophoblastic tumors
4. Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for Trophoblastic Neoplasia: Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society
5. Decentralized management of trophoblastic disease in the United States: Recent trends in patient care
6. Primary chemotherapy of nonmetastatic trophoblastic disease in women
7. Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms
8. Treatment of metastatic gestational trophoblastic disease: Good and poor prognosis
9. The New FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment
10. Ten years experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease
11. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease
12. Decision making for chemotherapy administration in patients with low risk gestational trophoblastic neoplasia
13. Single-dose actinomycin D in the treatment of postmolar trophoblastic disease
14. Hydatidiform mole in England and Wales 1973-83
15. Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve
16. Actinomycin D as the primary agent for gestational trophoblastic disease
17. Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors
18. Actinomycin-D toxicity in the treatment of trophoblastic disease: A comparison of the five day course to single dose administration
19. Single-dose actino-mycin-D treatment for nonmetastatic gestational trophoblastic disease
20. Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: Cost-effective chemotherapy
21. Is lack of response to single agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or dhemotherapy resistance?
22. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study)
23. Relationship of oral contraceptives to the development of trophoblastic tumor after evacuation of hydatidiform mole
24. Treatment of metastatic gestational trophoblastic disease
25. A prospective randomized comparison of methotrexate, dactinomycin and chlorambucil versus hydroxyurea and vincristine, methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan in "poor prognosis" metastatic gestational trophoblastic disease: A Gynecologic Oncology Group study
26. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole
27. Prevention of gestational trophoblastic disease by use of actinomycin D in molar pregnancies
28. The management of high risk choriocarcinoma
29. Results with EMA-CO (etoposide, methotrexate actinomycin-D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumors, 1979-1989
30. EMA/CO regimen in high risk gestational trophoblastic tumor
31. Etoposide, methotrexate, actinomycin, cyclophosphamide and vincristine for the treatment of metastatic, high risk gestational trophoblastic disease
32. Evaluating prognostic factors and staging in gestational trophoblastic tumor
33. EMACO in high risk gestational trophoblastic disease